An integral measure of serial neurofilament light chain assessments in blood is a predictor of long-term disability progression in relapsing-remitting multiple sclerosis

被引：0
|
作者：
Kuhle, J. [1 ,2 ,3 ,4 ]
Cohen, J. [5 ]
Haring, D. A. [6 ]
Kropshofer, H. [6 ]
Leppert, D. [6 ]
Tomic, D. [6 ]
Kappos, L. [1 ,2 ,3 ,4 ]
机构：
[1] Univ Hosp, Dept Med, Neurol Clin & Policlin, Basel, Switzerland
[2] Univ Hosp, Dept Biomed, Neurol Clin & Policlin, Basel, Switzerland
[3] Univ Hosp, Dept Clin Res, Neurol Clin & Policlin, Basel, Switzerland
[4] Univ Basel, Basel, Switzerland
[5] Cleveland Clin, Neurol Inst, Cleveland, OH 44106 USA
[6] Novartis Pharma AG, Basel, Switzerland
来源：
MULTIPLE SCLEROSIS JOURNAL | 2018年 / 24卷
基金：
新加坡国家研究基金会;
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1227
引用
收藏
页码：695 / 696
页数：2
相关论文
共 50 条
  • [1] Neurofilament light chain in human blood is a predictor of disease worsening in relapsing-remitting multiple sclerosis
    Kuhle, J.
    Kropshofer, H.
    Haring, D. A.
    Barro, C.
    Kappos, L.
    Leppert, D.
    Tomic, D.
    MULTIPLE SCLEROSIS JOURNAL, 2017, 23 : 298 - 299
  • [2] Long-term Effect of Fingolimod in Reducing Blood Neurofilament Light Levels in Patients with Relapsing-remitting Multiple Sclerosis
    Cohen, Jeffrey
    Kappos, Ludwig
    Tenenbaum, Nadia
    Han, Jackie
    Kropshofer, Harald
    Tomic, Davorka
    Kuhle, Jens
    NEUROLOGY, 2019, 92 (15)
  • [3] Long-term disease activity and disability progression in relapsing-remitting multiple sclerosis patients on natalizumab
    Dekker, I
    Leurs, C. E.
    Hagens, M. H. J.
    van Kempen, Z. L. E.
    Kleerekooper, I
    Lissenberg-Witte, B., I
    Barkhof, F.
    Uitdehaag, B. M. J.
    Balk, L. J.
    Wattjes, M. P.
    Killestein, J.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2019, 33 : 82 - 87
  • [4] Including Blood Neurofilament Light Chain in the NEDA Concept in Relapsing-Remitting Multiple Sclerosis Trials
    Sormani, Maria Pia
    Kappos, Ludwig
    Haring, Dieter
    Kropshofer, Harald
    Barro, Christian
    Leppert, David
    Tomic, Davorka
    Kuhle, Jens
    NEUROLOGY, 2018, 90
  • [5] Fingolimod and CSF neurofilament light chain levels in relapsing-remitting multiple sclerosis
    Kuhle, Jens
    Disanto, Giulio
    Lorscheider, Johannes
    Stites, Tracy
    Chen, Yu
    Dahlke, Frank
    Francis, Gordon
    Shrinivasan, Anupama
    Radue, Ernst-Wilhelm
    Giovannoni, Gavin
    Kappos, Ludwig
    NEUROLOGY, 2015, 84 (16) : 1639 - 1643
  • [6] Immunotherapies Improve Long-Term Disability Outcomes in Relapsing-Remitting Multiple Sclerosis
    Kalincik, Tomas
    Diouf, Ibrahima
    Malpas, Charles
    Horakova, Dana
    Havrdova, Eva
    Trojano, Maria
    Ayuso, Guillermo Izquierdo
    Eichau, Sara
    Onofrj, Marco
    Lugaresi, Alessandra
    Prat, Alexandre
    Girard, Marc
    Duquette, Pierre
    Grammond, Pierre
    Grand'Maison, Francois
    Sola, Patrizia
    Ferraro, Diana
    Shaygannejad, Vahid
    Alroughani, Raed
    Hupperts, R. M. M.
    Terzi, Murat
    Boz, Cavit
    Lechner-Scott, Jeannette
    Cartechini, Elisabetta
    Van Pesch, Vincent
    Iuliano, Gerardo
    Granella, Franco
    Bergamaschi, Roberto
    Fernandez Bolanos, Ricardo
    Spitaleri, Daniele Litterio A.
    Slee, Mark
    Vucic, Ostoja
    Ampapa, Radek
    McCombe, Pamela
    Ramo-Tello, Cristina
    Petersen, Thor
    Verheul, Freek
    Prevost, Julie
    Olascoaga Urtaza, Francisco Javier
    Cristiano, Edgardo
    Butzkueven, Helmut
    NEUROLOGY, 2020, 94 (15)
  • [7] Parity and disability progression in relapsing-remitting multiple sclerosis
    Achiron, Anat
    Ben-David, Alon
    Gurevich, Michael
    Magalashvili, David
    Menascu, Shay
    Dolev, Mark
    Stern, Yael
    Ziv-Baran, Tomer
    JOURNAL OF NEUROLOGY, 2020, 267 (12) : 3753 - 3762
  • [8] Natural Variation of Vitamin D and Neurofilament Light Chain in Relapsing-Remitting Multiple Sclerosis
    Rosjo, Egil
    Lindstrom, Jonas C.
    Holmoy, Trygve
    Myhr, Kjell-Morten
    Varhaug, Kristin N.
    Torkildsen, Oivind
    FRONTIERS IN NEUROLOGY, 2020, 11
  • [9] The impact of long-term treatment with disease modifying therapy on disability progression in relapsing-remitting multiple sclerosis patients
    Carra, Adriana J.
    Onaha, Patricia S.
    Sinay, Vladimiro
    Halfon, Mario J.
    MULTIPLE SCLEROSIS JOURNAL, 2008, 14 : S36 - S36
  • [10] Long-term outcome of minocycline in relapsing-remitting multiple sclerosis
    Zhang, Y.
    Metz, L. M.
    Yong, V. W.
    Bell, R. B.
    Yeung, M.
    Patry, D.
    Mitchel, J. R.
    MULTIPLE SCLEROSIS, 2007, 13 (09): : 1226 - 1226
12345